Treace Medical Concepts (TMCI) Short term Debt (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Short term Debt came in at $1.8 million in Q1 2026, up 3846.67% YoY from $45000.0 in Q1 2025, and up 1.78% on a QoQ basis from $1.7 million in Q4 2025.
Treace Medical Concepts (TMCI) Short term Debt (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 3 years of Short term Debt data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Short term Debt rose 3846.67% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 3846.67% YoY) and the FY2025 annual result came in at $1.7 million, changed N/A from the prior year.
- Short term Debt climbed to $1.8 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.8 million in Q3 2025 to a low of $45000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Treace Medical Concepts | 290.12 Mn | 244.50 Mn | 35.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.17 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2020 | 1.79 Mn |